Doxepin Tablet
FDA Label NDC 70771-1529

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Doxepin (NDC 70771-1529). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1528-3 in bottle of 30 tablets

Doxepin Tablets, 3 mg

Rx only

30 tablets

3 mg Label (6e32ce0d 2c99 4b03 B0a4 Ac723da0ef8c 01)

3 mg Label (6e32ce0d 2c99 4b03 B0a4 Ac723da0ef8c 01)

NDC 70771-1529-3 in bottle of 30 tablets

Doxepin Tablets, 6 mg

Rx only

30 tablets

6 mg Label (6e32ce0d 2c99 4b03 B0a4 Ac723da0ef8c 02)

6 mg Label (6e32ce0d 2c99 4b03 B0a4 Ac723da0ef8c 02)

* Please review the disclaimer below.